UnitedHealth Group Under Federal Inquiry Amid Medicare Advantage Probe and Leadership Shift

UnitedHealth Group (NYSE: UNH) is currently facing a federal inquiry concerning its Medicare Advantage practices. Concurrently, the company has seen leadership changes, including Stephen Hemsley's return as CEO. These developments are critical for the insurance giant as it navigates regulatory reviews and aims to stabilize its position in a dynamic market.